New drug effectively decreases recurrence of and death from endometrial cancer - News-Medical
New drug effectively decreases recurrence of and death from endometrial cancer News-Medical
Онкология
Исследования и наука
1636 материалов по теме, собраны автоматически из проверенных источников
Онкология
Fructose slows liver tumors in mice when key sugar-processing gene is missing, may lead to new treatments
Fructose is an important nutrient that, despite having a chemical structure very similar to that of glucose, is metabolized very differently in the body. Research into fructose metabolism and its regulation of metabolism in the human body has in recent years become a frontier topic in the life sciences and medicine. A…
Онкология
Biomarkers identified for cytokine release syndrome risk after CAR T-cell therapy
For patients with autoimmune disease, higher baseline B-cell counts and systemic inflammation are associated with development of cytokine release syndrome (CRS) after chimeric antigen receptor (CAR) T-cell therapy, according to a study published in the November issue of The Lancet Rheumatology.
Онкология
TroFuse-005 at ESMO 2026: Sacituzumab Tirumotecan Significantly Improves Overall Survival in Advanced Endometrial Cancer
TroFuse-005 at ESMO 2026: Sacituzumab Tirumotecan Significantly Improves Overall Survival in Advanced Endometrial Cancer Oncodaily
Онкология
ESMO26: The “paradigm-shifting” readouts in endometrial & ovarian cancer
ESMO26: The “paradigm-shifting” readouts in endometrial & ovarian cancer Clinical Trials Arena
Онкология
Nurse-Led Education Clears Up Clinical Trial Myths in Kidney Cancer
Nurse-Led Education Clears Up Clinical Trial Myths in Kidney Cancer Oncology Nursing News
Онкология
Seek Labs Expands Oncology Research for Sequence Ablation Therapeutics with Up to $3 Million in Foundation Support
Seek Labs Expands Oncology Research for Sequence Ablation Therapeutics with Up to $3 Million in Foundation Support Yahoo Finance
Онкология
Merck drug extends survival in endometrial cancer trial, wins US priority review
Merck drug extends survival in endometrial cancer trial, wins US priority review KSL News
Онкология
AI could help identify people at higher risk of common cancers using routine health data
Machine learning models using routinely collected health information, such as blood tests, medical history and lifestyle factors, could help identify people at higher risk of several common cancers, according to an international study reported at the ESMO Congress 2026.
Онкология
ESMO 2026: Merck’s Kelun-partnered ADC cuts death risk by over 30% in endometrial cancer
ESMO 2026: Merck’s Kelun-partnered ADC cuts death risk by over 30% in endometrial cancer BioSpace
Онкология
A new drug shows efficacy against advanced endometrial cancer, according to a phase 3 trial
A new drug shows efficacy against advanced endometrial cancer, according to a phase 3 trial Science Media Centre España
Онкология
Next-Gen Drug Significantly Prevents Return of and Death From Endometrial Cancer
Next-Gen Drug Significantly Prevents Return of and Death From Endometrial Cancer NYU Langone Health
Онкология
Next-generation drug reduces endometrial cancer progression and death in trial
A new drug is effective at decreasing the recurrence of, and death from, endometrial cancer, an international study shows. The drug, called sacituzumab tirumotecan (sac-TMT), attaches to a protein on the surface of tumor cells and then delivers a targeted dose of a chemical that leads to cancer cell death.
‹
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
›